NeuroXT Inc. is an innovative AI company that specializes in redefining brain imaging through advanced MRI-based technology. The company aims to enhance neurodegenerative care by providing leading MRI-based AI solutions that assist in diagnosis and treatment decisions without relying on PET scans. NeuroXT has developed a world-first multimodal platform designed to measure in-vivo synaptic integrity, enabling researchers to objectively verify the effectiveness of synapse-targeted therapies. Their NEXT-STAGE product leverages routine MRI to infer regional tau burden in a non-invasive, scalable, and cost-effective manner, making it an invaluable tool for biopharma research teams and academic hospitals.

Neuroxt

Neuroxt